These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 18414141

  • 1. Model mice for mild-form glycine encephalopathy: behavioral and biochemical characterizations and efficacy of antagonists for the glycine binding site of N-methyl D-aspartate receptor.
    Kojima-ishii K, Kure S, Ichinohe A, Shinka T, Narisawa A, Komatsuzaki S, Kanno J, Kamada F, Aoki Y, Yokoyama H, Oda M, Sugawara T, Mizoi K, Nakahara D, Matsubara Y.
    Pediatr Res; 2008 Sep; 64(3):228-33. PubMed ID: 18414141
    [Abstract] [Full Text] [Related]

  • 2. Direct correlation between ischemic injury and extracellular glycine concentration in mice with genetically altered activities of the glycine cleavage multienzyme system.
    Oda M, Kure S, Sugawara T, Yamaguchi S, Kojima K, Shinka T, Sato K, Narisawa A, Aoki Y, Matsubara Y, Omae T, Mizoi K, Kinouchi H.
    Stroke; 2007 Jul; 38(7):2157-64. PubMed ID: 17510459
    [Abstract] [Full Text] [Related]

  • 3. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.
    Bristow LJ, Hutson PH, Kulagowski JJ, Leeson PD, Matheson S, Murray F, Rathbone D, Saywell KL, Thorn L, Watt AP, Tricklebank MD.
    J Pharmacol Exp Ther; 1996 Nov; 279(2):492-501. PubMed ID: 8930150
    [Abstract] [Full Text] [Related]

  • 4. Structure and expression of the glycine cleavage system in rat central nervous system.
    Sakata Y, Owada Y, Sato K, Kojima K, Hisanaga K, Shinka T, Suzuki Y, Aoki Y, Satoh J, Kondo H, Matsubara Y, Kure S.
    Brain Res Mol Brain Res; 2001 Oct 19; 94(1-2):119-30. PubMed ID: 11597772
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Glycine cleavage system in neurogenic regions.
    Ichinohe A, Kure S, Mikawa S, Ueki T, Kojima K, Fujiwara K, Iinuma K, Matsubara Y, Sato K.
    Eur J Neurosci; 2004 May 19; 19(9):2365-70. PubMed ID: 15128390
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of neonatal N-methyl-D-aspartate receptor blockade on exploratory and anxiety-like behaviors in adult BALB/c and C57BL/6 mice.
    Akillioglu K, Binokay S, Kocahan S.
    Behav Brain Res; 2012 Jul 15; 233(1):157-61. PubMed ID: 22562039
    [Abstract] [Full Text] [Related]

  • 11. Treatment from birth of nonketotic hyperglycinemia due to a novel GLDC mutation.
    Korman SH, Wexler ID, Gutman A, Rolland MO, Kanno J, Kure S.
    Ann Neurol; 2006 Feb 15; 59(2):411-5. PubMed ID: 16404748
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hyperglycinemia due to folate deficiency in rats: evidence for the lack of involvement of the hepatic glycine cleavage system.
    Dickson TM, Edison E, Brosnan JT, House JD.
    J Nutr Biochem; 2005 Dec 15; 16(12):736-42. PubMed ID: 16081265
    [Abstract] [Full Text] [Related]

  • 19. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX, Kher SM, Zhou ZL, Ilyin V, Espitia SA, Tran M, Hawkinson JE, Woodward RM, Weber E, Keana JF.
    J Med Chem; 1997 Feb 28; 40(5):730-8. PubMed ID: 9057859
    [Abstract] [Full Text] [Related]

  • 20. 2,3-Dihydro-6,7-dichloro-pyrido[2,3-b]pyrazine-8-oxide as selective glycine antagonist with in vivo activity.
    Micheli F, Cugola A, Donati D, Missio A, Pecunioso A, Reggiani A, Tarzia G.
    Bioorg Med Chem; 1997 Dec 28; 5(12):2129-32. PubMed ID: 9459010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.